Clinical Trial Update: AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating NNC0487-0111 for weight loss and knee osteoarthritis pain in adults with obesity or overweight; the study is NOT_YET_RECRUITIN…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Osteoarthritis of the Knee
• Overweight

Drugs mentioned

• NNC0487-0111

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Obesity, Overweight | Phase 3 | Status: NOT_YET_RECRUITING